Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1689 studies found for:    "Perry syndrome" OR "Parkinsonian Disorders"
Show Display Options
Rank Status Study
21 Completed Low Dose Apomorphine and Parkinsonism
Condition: Parkinson's Disease
Intervention: Drug: apomorphine
22 Completed Mobilaser Study to Help With People Who Are Having Problems With Their Gait
Conditions: Parkinson's Disease;   Parkinsonism
Intervention: Device: Mobilaser
23 Recruiting Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and Parkinsonism
Condition: Parkinson's Disease
Intervention: Drug: 18F-DTBZ
24 Completed The Association of Neurotoxin Exposure With Parkinson's Disease and Parkinsonism in World War II Veterans and Other Men
Condition: Parkinson's Disease
Intervention:
25 Completed The Differential Diagnosis of Parkinson's Disease and Parkinsonism by Positron-emission Tomography
Condition: Parkinson's Disease
Intervention: Drug: 18F-FDG
26 Enrolling by invitation Providing Specialty Care to Individuals With Parkinsonism Directly in Their Homes Via Web-based Video Conferencing— A Comparative Effectiveness Study
Condition: Parkinson Disease
Interventions: Other: Telemedicine;   Other: Usual care
27 Completed Parkinsonism in Spinocerebellar Ataxia Type 6
Condition: Spinocerebellar Ataxia Type 6
Intervention:
28 Recruiting Parkinson's Families Project
Conditions: Parkinson's Disease;   Parkinsonism
Intervention:
29 Enrolling by invitation Molecular Analysis of Human Neural Stem Cells
Conditions: Parkinson's Disease;   Parkinsonism
Intervention: Procedure: Harvesting of neural stem cells
30 Completed
Has Results
Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)
Condition: Parkinson Disease
Interventions: Drug: SCH 420814 10 mg;   Drug: SCH 420814 100 mg;   Drug: Placebo;   Drug: Levodopa;   Drug: Carbidopa
31 Completed Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism
Condition: Sialorrhea
Interventions: Drug: Xeomin;   Drug: Placebo
32 Completed Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism
Condition: Parkinson's Disease
Intervention: Drug: 18F-DTBZ
33 Completed Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism
Conditions: Schizophrenia;   Extrapyramidal Syndrome
Intervention: Drug: Risperidone and Olanzapine
34 Completed Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
Conditions: Progressive Supranuclear Palsy;   Atypical Parkinsonism
Intervention: Drug: CoenzymeQ10
35 Recruiting Whole-body Vibration as a Treatment for Parkinson's Disease
Conditions: Idiopathic Parkinson's Disease;   Primary Parkinsonism
Interventions: Device: vibrating chair;   Device: sham treatment
36 Recruiting Evaluation of Safety and Tolerability of Fetal Mesencephalic Dopamine Neuronal Precursor Cells for Parkinson's Disease
Conditions: Idiopathic Parkinson Disease;   Primary Parkinsonism
Intervention: Drug: Mesencephalic Neuronal Precursor Cells
37 Completed Effect of Clonazepam on REM Sleep Behavior Disorder in Patients With Parkinsonism
Condition: REM Sleep Behavior Disorder
Interventions: Drug: Clonazepam;   Drug: Placebo
38 Active, not recruiting Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism
Conditions: Parkinson Disease;   Gaucher Disease;   Idiopathic Rapid Eye Movement Sleep Disorder
Intervention:
39 Completed Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)
Conditions: Dementia;   Parkinson Disease
Intervention: Drug: Quetiapine
40 Withdrawn Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
Conditions: Parkinson Disease;   Amyotrophic Lateral Sclerosis
Interventions: Drug: Xeomin;   Drug: placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.